Intensive Care Emergency Articles & Analysis
9 news found
” Results from the analytical and clinical studies conclude that the Symphony IL-6 Test is an innovative technology for use in Emergency Department and Intensive Care Unit settings to identify COVID-19 patients at higher risk for severe disease, including the requirement for Invasive Mechanical Ventilation (IMV). ...
Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview University of Minnesota Medical ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the publication of results from the Company’s U.S. ...
As we continue to achieve regulatory milestones that broaden the availability of glucarpidase globally, we grow more excited for Voraxaze’s potential to improve the care of cancer patients around the world.” In August of 2020 BTG submitted a Marketing Authorisation Application for Voraxaze® (glucarpidase) with the European Medicines Agency (EMA) for the treatment ...
We are committed to the continued growth of VeinViewer® as a standard of care and are excited to partner with DO-PA Inc. as our authorized distributor for Turkey.DO-PA A.S. is one of the oldest medical distribution companies in Turkey and has experience in obstetrics, cardiovascular surgery, plastic and general surgery, aesthetics, emergency, and ...
This is one of the latest extensions of VUNO’s ambition to leverage the full potential of AI to better orchestrate clinical workflows by empowering medical service providers to deliver patient-focused care. VUNO’s AI algorithm has been successfully validated for its improved clinical utility and efficiency in academic journals and clinical settings. ...
The medical device enables rapid, repeatable, and trusted hemodynamic assessments throughout the continuum of care, including emergency department and intensive care unit patients with COVID-19. ...
Abionic SA, a developer of disruptive nanotechnology based rapid diagnostic solutions, announced today the successful completion of its multi-center observational study using Abionic’s novel point-of-care Pancreatic Stone Protein (PSP) sepsis test on the abioSCOPE® platform. ...
The results of the assay are intended to aid in: assessing the risk of critically ill patients on their first day of intensive care unit (ICU) admission for progression to severe sepsis and septic shock; determining the change in PCT level over time as an aid in assessing the cumulative 28-day risk of all-cause mortality for patients diagnosed with severe ...